Medicenna Therapeutics Quote - MDNA

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.157

Bid

0.1565

Ask

0.1612

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

10.933M

Previous Close

0.157

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

69,637,000

Dividend Yield

PE Ratio

-4.35

Earnings Per Share (EPS)

-0.37

Revenue

Net Profit

-25.47M

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.medicenna.com

Headquarters

Toronto, Ontario, Can

Founded

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MDNA - Frequently Asked Questions (FAQ)

What is the current Medicenna Therapeutics share price?

The current share price of Medicenna Therapeutics is US$ 0.157

How many Medicenna Therapeutics shares are in issue?

Medicenna Therapeutics has 69,637,000 shares in issue

What is the market cap of Medicenna Therapeutics?

The market capitalisation of Medicenna Therapeutics is USD 10.93M

What is the 1 year trading range for Medicenna Therapeutics share price?

Medicenna Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Medicenna Therapeutics?

The price to earnings ratio of Medicenna Therapeutics is -4.35

What is the reporting currency for Medicenna Therapeutics?

Medicenna Therapeutics reports financial results in CAD

What is the latest annual profit for Medicenna Therapeutics?

The latest annual profit of Medicenna Therapeutics is CAD -25.47M

What is the registered address of Medicenna Therapeutics?

The registered address for Medicenna Therapeutics is 200 - 1920 YONGE STREET, TORONTO, ONTARIO, M4S 3E2

What is the Medicenna Therapeutics website address?

The website address for Medicenna Therapeutics is www.medicenna.com

Which industry sector does Medicenna Therapeutics operate in?

Medicenna Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
CRNCCerence Inc	US$ 19.33 (143.76%)	161.8M
KITTNauticus Robotics Inc	US$ 3.8249 (140.56%)	104.8M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
HWHHWH International Inc	US$ 0.4621 (-28.80%)	7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5.69 (-26.30%)	24.77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5.59 (-23.42%)	161.15k
PTLEPTL Ltd	US$ 9.35 (-23.30%)	1.04M
NXUNXU Inc	US$ 0.725868 (-22.78%)	7.59M
NITON2OFF Inc	US$ 2.6306 (145.85%)	350.92M
TGLTreasure Global Inc	US$ 0.382 (101.58%)	330.82M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.59M
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	259.78M
NVDANVIDIA Corporation	US$ 144.47 (4.45%)	222.72M